Winton Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,485
| Closed | -$288K | – | 910 |
|
|
2023
Q1 | $288K | Buy |
+3,485
| New | +$288K | 0.02% | 826 |
|
|
2021
Q4 | – | Sell |
-25,517
| Closed | -$1.8M | – | 1174 |
|
|
2021
Q3 | $1.8M | Sell |
25,517
-3,316
| -12% | -$234K | 0.1% | 227 |
|
|
2021
Q2 | $1.92M | Buy |
28,833
+14,090
| +96% | +$939K | 0.1% | 204 |
|
|
2021
Q1 | $1.64M | Buy |
14,743
+2,290
| +18% | +$254K | 0.09% | 212 |
|
|
2020
Q4 | $1.48M | Sell |
12,453
-18,033
| -59% | -$2.14M | 0.11% | 221 |
|
|
2020
Q3 | $2.66M | Buy |
30,486
+2,597
| +9% | +$227K | 0.09% | 394 |
|
|
2020
Q2 | $2.5M | Sell |
27,889
-3,367
| -11% | -$302K | 0.06% | 538 |
|
|
2020
Q1 | $3.12M | Buy |
31,256
+9,892
| +46% | +$986K | 0.08% | 423 |
|
|
2019
Q4 | $2.46M | Sell |
21,364
-9,352
| -30% | -$1.07M | 0.03% | 724 |
|
|
2019
Q3 | $3.88M | Buy |
30,716
+193
| +0.6% | +$24.3K | 0.05% | 383 |
|
|
2019
Q2 | $3.67M | Buy |
+30,523
| New | +$3.67M | 0.07% | 232 |
|
|
2018
Q2 | – | Sell |
-8,371
| Closed | -$612K | – | 1077 |
|
|
2018
Q1 | $612K | Sell |
8,371
-99,353
| -92% | -$7.26M | 0.02% | 681 |
|
|
2017
Q4 | $6.26M | Buy |
+107,724
| New | +$6.26M | 0.18% | 162 |
|